Asset Management, LP Cormorant

GLUE

Asset Management, LP Cormorant serves as an insider at Monte Rosa Therapeutics, Inc. (GLUE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$11.40M

Total Sells

1 trades

$942.2K

Net Position

Net Buyer

$10.46M

Companies Traded

EYPT, GLUE

Active Period

Jun 2021 – Dec 2025

2 total trades

Most Recent

Sell EYPT

Dec 8, 2025 · $942.2K

Asset Management, LP Cormorant's Insider Trading at Monte Rosa Therapeutics, Inc. (GLUE)

Buys

1 · $11.40M

Sells

0 · $0.00

Total Shares Bought

600,000

Total Shares Sold

GLUE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 30, 2021↗	Buy	600,000	$19.00	$11.40M	3,202,200

Asset Management, LP Cormorant's Insider Trading at EyePoint Pharmaceuticals, Inc. (EYPT)

Buys

0 · $0.00

Sells

1 · $942.2K

Total Shares Bought

Total Shares Sold

60,000

EYPT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 8, 2025↗	Sell	60,000	$15.70	$942.2K	8,265,000

Related Insiders

Ramiro Ribeiro

officer: Chief Medical Officer

EYPTSell · Mar 4, 2026

Edmund Dunn

officer: Principal Accounting Officer

GLUESell · Mar 4, 2026

Markus Warmuth

director, officer: President & CEO

GLUESell · Mar 2, 2026

Filip Janku

Chief Medical Officer

GLUESell · Feb 23, 2026

Filip Janku

officer: Chief Medical Officer

GLUESell · Feb 23, 2026

Ramiro Ribeiro

Chief Medical Officer

EYPTSell · Feb 17, 2026

Jennifer Champoux

officer: Chief Operating Officer

GLUESell · Jan 5, 2026

Edmund Dunn

Principal Accounting Officer

GLUESell · Jan 5, 2026

Explore More Insider Trading Data

GLUE Insider Trading Activity

View all insider trades at Monte Rosa Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity